URSO in obstetric cholestasis: not a bear market
Author:
Open Access
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancyThe Lancet, 1999
- Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placentaJournal of Hepatology, 1998
- Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancyJournal of Hepatology, 1998
- Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized double-blind study controlled with placeboJournal of Hepatology, 1997
- Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancyJournal of Hepatology, 1997
- Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: Effect of ursodeoxycholic acid therapyHepatology, 1997
- The adverse influence of pregnancy upon sulphation: a clue to the pathogenesis of intrahepatic cholestasis of pregnancy?Journal of Hepatology, 1994
- Ursodeoxycholic acid in intrahepatic cholestasis of pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 1994
- Effects of Ursodeoxycholic Acid in Patients With Intrahepatic Cholestasis of PregnancyHepatology, 1992
- Fetal outcome in obstetric cholestasisBJOG: An International Journal of Obstetrics & Gynaecology, 1988